Consolidated Portfolio Review Corp’s Aberdeen India Fund IFN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-121,534
Closed -$1.78M 210
2025
Q3
$1.78M Buy
121,534
+2,445
+2% +$37.8K 0.22% 117
2025
Q2
$1.97M Buy
119,089
+4,794
+4% +$76.2K 0.27% 92
2025
Q1
$1.8M Buy
114,295
+8,314
+8% +$130K 0.29% 89
2024
Q4
$1.67M Buy
105,981
+619
+0.6% +$10.9K 0.26% 101
2024
Q3
$2M Buy
105,362
+10,121
+11% +$185K 0.45% 56
2024
Q2
$1.7M Buy
95,241
+13,418
+16% +$244K 0.4% 63
2024
Q1
$1.67M Buy
81,823
+1,863
+2% +$36.7K 0.44% 64
2023
Q4
$1.46M Sell
79,960
-1,484
-2% -$25.5K 0.33% 79
2023
Q3
$1.42M Sell
81,444
-7,997
-9% -$135K 0.34% 82
2023
Q2
$1.48M Buy
89,441
+1,724
+2% +$26.9K 0.35% 81
2023
Q1
$1.33M Buy
+87,717
New +$1.36M 0.36% 74

Other funds holding IFN

Consolidated Portfolio Review Corp's IFN Position: Q4 2025 in Review

Consolidated Portfolio Review Corp sold out of Aberdeen India Fund (IFN) in Q4 2025, closing a stake of 121,534 shares — an estimated $1.78M sold.

Consolidated Portfolio Review Corp first reported a position in IFN in Q1 2023 and held it in 11 quarters. The position peaked at $2M in Q3 2024. 72 funds tracked by Wall St. Rank hold IFN as of Q4 2025.

  • Consolidated Portfolio Review Corp reported no remaining Aberdeen India Fund position as of Q4 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 121,534 Aberdeen India Fund shares in Q4 2025, an estimated $1.78M.
  • Consolidated Portfolio Review Corp first reported a position in Aberdeen India Fund in Q1 2023 and held it in 11 quarters.
  • Consolidated Portfolio Review Corp's Aberdeen India Fund position peaked at $2M in Q3 2024.
  • 72 funds tracked by Wall St. Rank held Aberdeen India Fund as of Q4 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q4 2025, filed 26 Jan 2026.